Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Is that a fake wall at .45.
View:
Post by chry200030 on Apr 01, 2022 2:32pm

Is that a fake wall at .45.

Trying to push it down?  Games, Games.
Comment by Lesalpes29 on Apr 01, 2022 2:36pm
Don’t know for sure. Same pattern almost all week long. Pushed up And pushed down in few minutes.
Comment by Lesalpes29 on Apr 01, 2022 3:24pm
Now big bid at .45. I'm part of it!
Comment by jewel9m on Apr 01, 2022 3:30pm
Someone with house (7) has been trying to keep a lid on this for the last several weeks. Everytime we hit .465 or .47 they sell down and put up a wall. Not sure their motive or game plan but interesting to watch and see how this plays out.
Comment by CAinPlap on Apr 01, 2022 3:41pm
Oh the fun we could have if we had the war chest to scoop up all the shares they are putting up in attempting to put up said wall. ;) Glass half empty - no NR this week. :( Glass half full - one week closer to news. :)
Comment by Scorpio2 on Apr 01, 2022 7:57pm
I think their motive is that as soon as the data from Phase 2 is sufficient enough to satisfy the FDA to provide TLT with the BTD accreditation, that means commercialization is a done deal and they (the potential acquirer) will make their move on TLT. They should already know exactly what we have, what the future revenue stream will be along with the NPV and will have ticked all of their boxes ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250